Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.

Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.

<h4>Background</h4> <p>Antimalarial drugs affect the central nervous system, but it is difficult to differentiate the effect of these drugs from that of the malaria illness. We conducted a systematic review to determine the association between anti-malarial drugs and mental and ne...

書誌詳細
主要な著者:	Bitta, M, Kariuki, S, Mwita, C, Gwer, S, Mwai, L, Newton, C
フォーマット:	Journal article
言語:	English
出版事項:	Wellcome et al 2017

類似資料

Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis [version 2; referees: 2 approved]
著者:: Mary A. Bitta, 等
出版事項: (2017-06-01)

Diagnostic accuracy of clinical stroke scores for distinguishing stroke subtypes: A systematic review
著者:: Mwita, C, 等
出版事項: (2012)

Antiepileptic properties of quinine: A systematic review
著者:: Mwita, C, 等
出版事項: (2012)

Priority mental, neurological and substance use disorders in rural Kenya: Traditional health practitioners’ and primary health care workers’ perspectives
著者:: Bitta, M, 等
出版事項: (2019)

Burden of neurodevelopmental disorders in low and middle-income countries: A systematic review and meta-analysis
著者:: Bitta, M, 等
出版事項: (2017)

Effectiveness of participatory video in lowering stigma against people with mental, neurological and substance use disorders in Kenya
著者:: Bitta, MA, 等
出版事項: (2023)

The role for osmotic agents in children with acute encephalopathies: a systematic review
著者:: Gwer, S, 等
出版事項: (2010)

Risk of suicidality in mental and neurological disorders in low and middle-income countries: A systematic review and meta-analysis
著者:: Ongeri, L, 等
出版事項: (2023)

Accuracy of clinical stroke scores for distinguishing stroke subtypes in resource poor settings: A systematic review of diagnostic test accuracy.
著者:: Mwita, C, 等
出版事項: (2014)

An overview of mental health care system in Kilifi, Kenya: results from an initial assessment using the World Health Organization's Assessment Instrument for Mental Health Systems.
著者:: Bitta, M, 等
出版事項: (2017)

Priority mental, neurological and substance use disorders in rural Kenya: Traditional health practitioners' and primary health care workers' perspectives.
著者:: Mary A Bitta, 等
出版事項: (2019-01-01)

The activities of various antimalarial drugs on Plasmodium falciparum isolates in Kilifi Kenya and studies on mechanisms of resistance
著者:: Mwai, L
出版事項: (2011)

Neurological manifestations of falciparum malaria.
著者:: Newton, C, 等
出版事項: (1998)

Risk of suicidality in mental and neurological disorders in low and middle-income countries: A systematic review and meta-analysis
著者:: Linnet Ongeri, 等
出版事項: (2023-05-01)

The role for osmotic agents in children with acute encephalopathies: a systematic review
著者:: Mwai Leah, 等
出版事項: (2010-04-01)

Public Awareness and Identification of Counterfeit Drugs in Tanzania: A View on Antimalarial Drugs
著者:: Linus Mhando, 等
出版事項: (2016-01-01)

The effectiveness of a multipronged approach to tackle stigma against people with mental, neurological and substance use disorders in Kilifi, Kenya
著者:: Bitta, MA
出版事項: (2022)

Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
著者:: Earnest Oghenesuvwe Erhirhie, 等
出版事項: (2021-01-01)

Antimalarial drug quality: Methods to detect suspect drugs
著者:: Kaur, H, 等
出版事項: (2010)

Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.
著者:: Tâmara Natasha Gonzaga de Andrade Santos, 等
出版事項: (2020-01-01)

An overview of mental health care system in Kilifi, Kenya: results from an initial assessment using the World Health Organization’s Assessment Instrument for Mental Health Systems
著者:: Mary A. Bitta, 等
出版事項: (2017-04-01)

Monitoring antimalarial drug efficacy - Reply
著者:: Mayxay, M, 等
出版事項: (2004)

A link between poor quality antimalarials and malaria drug resistance?
著者:: Newton, P, 等
出版事項: (2016)

A link between poor quality antimalarials and malaria drug resistance?
著者:: Newton, P, 等
出版事項: (2016)

Prevalence of neurological manifestations in COVID-19 and their association with mortality
著者:: C.R. Carlos, 等
出版事項: (2021-01-01)

Prevalence of malaria and predisposing factors to antimalarial drug resistance in Ota
著者:: G.I. Olasehinde
出版事項: (2014-04-01)

Quality of Antimalarial Drugs in East Africa: A Systematic Review
著者:: Girma M, 等
出版事項: (2022-10-01)

Neurological manifestations of malaria
著者:: Gustavo C. Román, 等
出版事項: (1992-03-01)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
著者:: Shibeshi MA, 等
出版事項: (2020-11-01)

Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis
著者:: Rizaldy Taslim Pinzon, 等
出版事項: (2022-08-01)

A systematic overview of published antimalarial drug trials.
著者:: Myint, H, 等
出版事項: (2004)

Antimalarial drugs in pregnancy: a review.
著者:: Nosten, F, 等
出版事項: (2006)

Neurological manifestations of coronavirus infections – a systematic review
著者:: Jesper Almqvist, 等
出版事項: (2020-10-01)

Neurological manifestations of COVID-19: a systematic review
著者:: Gaurav Nepal, 等
出版事項: (2020-07-01)

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
著者:: Price, R, 等
出版事項: (2007)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
著者:: Price, R, 等
出版事項: (2007)

Antimalarial drug resistance
著者:: White, N
出版事項: (2004)

Cardiotoxicity of antimalarial drugs.
著者:: White, N
出版事項: (2007)

Antimalarial drug resistance.
著者:: White, N
出版事項: (2004)

Effectiveness of antimalarial drugs.
著者:: Baird, J
出版事項: (2005)